Should nonalcoholic fatty liver disease be regarded as a hepatic illness only?
- PMID: 17729388
- PMCID: PMC4611188
- DOI: 10.3748/wjg.v13.i35.4669
Should nonalcoholic fatty liver disease be regarded as a hepatic illness only?
Abstract
The highly increasing prevalence of obesity and type 2 diabetes mellitus in the general population makes nonalcoholic fatty liver disease the most common diagnosis in every-day practices. Lifestyle changes (mainly exercise withdrawal and weight gain) have probably heightened the prevalence of nonalcoholic fatty liver disease. Mortality in patients with Nonalcoholic Fatty Liver Disease is significantly higher when compared with that of the same age-gender general population. Hepatologists claim to bear a new burden, being Nonalcoholic Fatty Liver Disease strongly linked to systemic diseases.
Similar articles
-
Obesity and nonalcoholic fatty liver disease.Nutr Rev. 2007 Jun;65(6 Pt 2):S57-63. doi: 10.1111/j.1753-4887.2007.tb00329.x. Nutr Rev. 2007. PMID: 17605315 Review.
-
Non-alcoholic fatty liver disease, obesity and the metabolic syndrome.Best Pract Res Clin Gastroenterol. 2014 Aug;28(4):637-53. doi: 10.1016/j.bpg.2014.07.008. Epub 2014 Jul 11. Best Pract Res Clin Gastroenterol. 2014. PMID: 25194181 Review.
-
Nonalcoholic fatty liver disease and the metabolic syndrome.Curr Opin Lipidol. 2005 Aug;16(4):421-7. doi: 10.1097/01.mol.0000174153.53683.f2. Curr Opin Lipidol. 2005. PMID: 15990591 Review.
-
The Future of Nonalcoholic Fatty Liver Disease Treatment.Med Clin North Am. 2019 Jan;103(1):57-69. doi: 10.1016/j.mcna.2018.08.005. Epub 2018 Nov 1. Med Clin North Am. 2019. PMID: 30466676 Review.
-
The metabolic syndrome as a predictor of nonalcoholic fatty liver disease.Ann Intern Med. 2005 Nov 15;143(10):722-8. doi: 10.7326/0003-4819-143-10-200511150-00009. Ann Intern Med. 2005. PMID: 16287793
Cited by
-
Liver apoptosis is age dependent and is reduced by activation of peroxisome proliferator-activated receptor-gamma in hemorrhagic shock.Am J Physiol Gastrointest Liver Physiol. 2010 Jan;298(1):G133-41. doi: 10.1152/ajpgi.00262.2009. Epub 2009 Nov 19. Am J Physiol Gastrointest Liver Physiol. 2010. PMID: 19926821 Free PMC article.
-
Oxidative Stress and Periodontal Disease in Obesity.Medicine (Baltimore). 2016 Mar;95(12):e3136. doi: 10.1097/MD.0000000000003136. Medicine (Baltimore). 2016. PMID: 27015191 Free PMC article.
-
Anti-obesity effect of Solidago virgaurea var. gigantea extract through regulation of adipogenesis and lipogenesis pathways in high-fat diet-induced obese mice (C57BL/6N).Food Nutr Res. 2017 Feb 13;61(1):1273479. doi: 10.1080/16546628.2016.1273479. eCollection 2017. Food Nutr Res. 2017. PMID: 28326002 Free PMC article.
-
Predictive Value of Serum Gamma-glutamyltranspeptidase for Future Cardiometabolic Dysregulation in Adolescents- a 10-year longitudinal study.Sci Rep. 2017 Aug 29;7(1):9636. doi: 10.1038/s41598-017-09719-8. Sci Rep. 2017. PMID: 28851958 Free PMC article.
-
Pathogenesis of hepatic steatosis: the link between hypercortisolism and non-alcoholic fatty liver disease.World J Gastroenterol. 2013 Oct 28;19(40):6735-43. doi: 10.3748/wjg.v19.i40.6735. World J Gastroenterol. 2013. PMID: 24187449 Free PMC article. Review.
References
-
- Boza C, Riquelme A, Ibañez L, Duarte I, Norero E, Viviani P, Soza A, Fernandez JI, Raddatz A, Guzman S, et al. Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass. Obes Surg. 2005;15:1148–1153. - PubMed
-
- Xanthakos S, Miles L, Bucuvalas J, Daniels S, Garcia V, Inge T. Histologic spectrum of nonalcoholic fatty liver disease in morbidly obese adolescents. Clin Gastroenterol Hepatol. 2006;4:226–232. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical